MUSTANG BIO, INC. — Form D/A
MUSTANG BIO, INC. of WORCESTER, MA, a company, filed a Form D amendment with the SEC on 2016-12-13. The offering totals $70.0M, of which $31.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-12-13
- Form: D/A
- Accession: 0001680048-16-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $70.0M
- Amount sold: $31.9M
- Remaining: $38.1M
- Investors: 390
- Date of first sale: 2016-11-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-272604
Issuer
- Name: MUSTANG BIO, INC.
- CIK: 0001680048
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 377 PLANTATION STREET, WORCESTER, MA, 01605
- Phone: 7816524500
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Manuel B Litchman, M.D. | Director | WORCESTER, MA |
| Manuel B Litchman, M.D. | Executive Officer | WORCESTER, MA |
| Adam J Chill | Director | WORCESTER, MA |
| Michael J Zelefsky, M.D. | Director | WORCESTER, MA |
| James B Murphy | Executive Officer | WORCESTER, MA |
| Neil A Herskowitz | Director | WORCESTER, MA |
| Lindsay A Rosenwald, M.D. | Director | WORCESTER, MA |
| Manuel S Litchman, M.D. | Director | Worcester, MA |
| Manuel S Litchman, M.D. | Executive Officer | Worcester, MA |
| Eliot S Lurier | Executive Officer | Worcester, MA |
| Michael S Weiss | Director | New York, NY |
| Michael S Weiss | Executive Officer | New York, NY |
| Lindsay A Rosenwald | Director | New York, NY |
Other filings by this issuer (8)
More